| High absolute monocyte count predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy K Shigeta, T Kosaka, S Kitano, Y Yasumizu, Y Miyazaki, R Mizuno, ... Annals of surgical oncology 23, 4115-4122, 2016 | 44 | 2016 |
| The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma … K Ogihara, E Kikuchi, K Shigeta, T Okabe, S Hattori, R Yamashita, ... Urologic Oncology: Seminars and Original Investigations 38 (6), 602. e1-602. e10, 2020 | 38 | 2020 |
| Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer K Shigeta, T Kosaka, S Yazawa, Y Yasumizu, R Mizuno, H Nagata, ... International journal of clinical oncology 20, 605-612, 2015 | 38 | 2015 |
| The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma K Shigeta, E Kikuchi, M Hagiwara, T Ando, R Mizuno, T Abe, S Mikami, ... The Journal of Urology 198 (6), 1278-1285, 2017 | 36 | 2017 |
| Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including … Y Arita, K Shigeta, H Akita, T Suzuki, R Kufukihara, TC Kwee, R Ishii, ... European radiology 31, 875-883, 2021 | 33 | 2021 |
| Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies E Kikuchi, N Hayakawa, K Fukumoto, K Shigeta, K Matsumoto International Journal of Urology 27 (2), 108-116, 2020 | 26 | 2020 |
| Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma K Shigeta, M Hasegawa, E Kikuchi, Y Yasumizu, T Kosaka, R Mizuno, ... Cancer science 111 (10), 3639-3652, 2020 | 23 | 2020 |
| Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma K Shigeta, E Kikuchi, M Hagiwara, T Ando, R Mizuno, A Miyajima, ... Surgical Oncology 26 (1), 73-79, 2017 | 19 | 2017 |
| IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer K Shigeta, M Hasegawa, T Hishiki, Y Naito, Y Baba, S Mikami, ... The EMBO Journal 42 (4), e110620, 2023 | 15 | 2023 |
| Long-term oncologic outcomes of laparoscopic versus open radical nephroureterectomy for patients with T3N0M0 upper tract urothelial carcinoma: a multicenter cohort study with … K Shigeta, E Kikuchi, T Abe, M Hagiwara, K Ogihara, T Anno, K Umeda, ... Annals of surgical oncology 26, 3774-3781, 2019 | 15 | 2019 |
| Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, ... Urologic Oncology: Seminars and Original Investigations 40 (3), 105. e19-105 …, 2022 | 14 | 2022 |
| A novel risk-based approach simulating oncological surveillance after radical nephroureterectomy in patients with upper tract urothelial carcinoma K Shigeta, E Kikuchi, T Abe, M Hagiwara, K Ogihara, T Anno, K Umeda, ... European urology oncology 3 (6), 756-763, 2020 | 13 | 2020 |
| Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration K Shigeta, T Kosaka, H Hongo, Y Yanai, K Matsumoto, S Morita, R Mizuno, ... International Journal of Clinical Oncology 24, 546-553, 2019 | 13 | 2019 |
| Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up … A Ikeda, T Kojima, K Kawai, S Hinotsu, N Keino, K Shiga, H Miyake, ... International Journal of Clinical Oncology 25, 1163-1169, 2020 | 12 | 2020 |
| Accidental hypothermia treated by hemodialysis in the acute phase: three case reports and a review of the literature T Murakami, T Yoshida, A Kurokochi, K Takamatsu, Y Teranishi, ... Internal Medicine 58 (18), 2743-2748, 2019 | 12 | 2019 |
| Evaluating the oncological outcomes of pure laparoscopic radical nephroureterectomy performed for upper-tract urothelial carcinoma patients: a multicenter cohort study adjusted … K Shigeta, K Matsumoto, T Takeda, S Hattori, G Kaneko, M Matsushima, ... Annals of Surgical Oncology 28, 465-473, 2021 | 11 | 2021 |
| Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic … R Kufukihara, E Kikuchi, K Shigeta, K Ogihara, Y Arita, H Akita, T Suzuki, ... Urologic Oncology: Seminars and Original Investigations 40 (2), 61. e1-61. e8, 2022 | 10 | 2022 |
| The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, ... Cancer science 112 (3), 1084-1094, 2021 | 10 | 2021 |
| Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer K Hakozaki, E Kikuchi, K Ogihara, K Shigeta, T Abe, Y Miyazaki, ... Japanese journal of clinical oncology 51 (2), 287-295, 2021 | 9 | 2021 |
| A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis. L Afferi, M Abufaraj, F Soria, D D'Andrea, E Xylinas, T Seisen, M Roupret, ... Minerva Urology and Nephrology 74 (1), 49-56, 2021 | 8 | 2021 |
